PL362711A1
(en )
2004-11-02
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
IL150742A0
(en )
2003-02-12
Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IL159344A0
(en )
2004-06-01
Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL196301A0
(en )
2009-09-22
Medicament for the treatment of hapatitis c
IL145470A0
(en )
2002-06-30
Compositions for the treatment of immune diseases
IL160884A0
(en )
2004-08-31
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
IL151890A0
(en )
2003-04-10
Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
EP1463527A4
(en )
2005-05-11
The use of gammaglobulin for the treatment of immune-mediated diseases
HUP0400024A3
(en )
2007-05-29
Combination for treatment of neoplastic diseases
HK1051485A1
(en )
2003-08-08
Treatment of hyperproliferative disorders
HUP0104963A3
(en )
2002-11-28
Compositions for the treatment of skin diseases
IL151891A0
(en )
2003-04-10
Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0
(en )
2003-04-10
Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL133760A0
(en )
2001-04-30
Composition for the treatment of dandruff
ZA200110539B
(en )
2003-03-24
Oxazinocarbazoles for the treatment of CNS diseases.
CZ20011872A3
(en )
2002-03-13
Isonipecotamides for the treatment of integrin-mediated disorders
IL154378A0
(en )
2003-09-17
Compounds for the treatment of addictive disorders
PT1698338E
(en )
2008-06-03
S-methyl-dihydro-ziprasidone for the treatment of schizophrenia
HUP0202865A3
(en )
2005-01-28
Process for the preparation of 2-cyanopyridines
IL138691A
(en )
2005-03-20
Process for the preparation of 3-acyl-indoles
GB0028484D0
(en )
2001-01-10
Imidazolone derivatives for the treatment of viral diseases
SI1200447T1
(en )
2004-04-30
Oxazinocarbazoles for the treatment of cns diseases
GB9904252D0
(en )
1999-04-21
Composition for the treatment of pain
GB9926985D0
(en )
2000-01-12
Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases
GB9923551D0
(en )
1999-12-08
Treatment of neuropsychiatric disorders